IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
Sweden · Delayed Price · Currency is SEK 1.246
-0.042 (-3.26%)
May 21, 2026, 11:13 AM CET
IRLAB Therapeutics AB Market Cap
IRLAB Therapeutics AB has a market cap or net worth of 109.4 million as of May 21, 2026. Its market cap has decreased by -69.43% in one year.
Market Cap
109.40M
Enterprise Value
85.70M
Revenue
92.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.25
Market Cap Chart
Since February 28, 2017, IRLAB Therapeutics AB's market cap has decreased from 413.00M to 109.40M, a decrease of -73.51%. That is a compound annual growth rate of -13.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 109.40M | -34.62% |
| Dec 30, 2025 | 167.33M | -69.99% |
| Dec 30, 2024 | 557.59M | 43.33% |
| Dec 29, 2023 | 389.01M | -80.42% |
| Dec 30, 2022 | 1.99B | -12.75% |
| Dec 30, 2021 | 2.28B | 4.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Simris Group AB (PUBL) | 141.05M |
| Alligator Bioscience AB | 140.70M |
| Magle Chemoswed Holding AB | 119.55M |
| NextCell Pharma AB | 118.30M |
| Annexin Pharmaceuticals AB | 105.18M |
| AcouSort AB | 103.28M |
| Biovica International AB | 101.29M |
| Scandinavian ChemoTech AB | 92.91M |